.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Novartis
Farmers Insurance
Queensland Health
Teva
AstraZeneca
Cipla
Accenture
Daiichi Sankyo
Boehringer Ingelheim

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022181

« Back to Dashboard
NDA 022181 describes KUVAN, which is a drug marketed by Biomarin Pharm and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug and three Paragraph IV challenges. Additional details are available on the KUVAN profile page.

The generic ingredient in KUVAN is sapropterin dihydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sapropterin dihydrochloride profile page.

Summary for NDA: 022181

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Enzyme Replacements/Modifiers

Pharmacology for NDA: 022181

Mechanism of ActionPhenylalanine Hydroxylase Activators
Breast Cancer Resistance Protein Inhibitors
P-Glycoprotein Inhibitors

Suppliers and Packaging for NDA: 022181

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KUVAN
sapropterin dihydrochloride
 TABLET;ORAL 022181 NDA BioMarin Pharmaceutical Inc. 68135-300 68135-300-02 120 TABLET in 1 BOTTLE (68135-300-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 13, 2007TE:RLD:Yes
Patent:7,566,462*PEDPatent Expiration:May 16, 2026Product Flag?Substance Flag?Delist Request?Y
Patent:7,566,714*PEDPatent Expiration:May 17, 2025Product Flag?Substance Flag?Delist Request?Y
Patent:7,612,073*PEDPatent Expiration:May 17, 2025Product Flag?Substance Flag?Delist Request?Y


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
McKinsey
Cantor Fitzgerald
Deloitte
Chinese Patent Office
Federal Trade Commission
Harvard Business School
McKesson
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot